Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

15 more items receive concessionary prices for July

The Department of Health and Social Care and the National Assembly for Wales have agreed concessionary prices for a further 15 items for July 2018 prescriptions.

An initial 13 items received concessionary prices on July 25, with a further 15 prices announced two days later.

Drug
Strength
Form
Price
Brimonidine
0.2%
eye drops (5)
£3.00
Fexofenadine
180mg
tablets (30)
£2.99
Lamotrigine
100mg
tablets (56)
£15.00
Lamotrigine
200mg
tablets (56)
£22.31
Lamotrigine
50mg
tablets (56)
£8.50
Latanoprost/timolol
50 micrograms/ml, 5mg/ml
eye drops (2.5)
£5.05
Levetiracetam
100mg/ml
sugar-free oral solution (300)
£15.90
Metronidazole
400mg
tablets (21)
£3.40
Mometasone
0.1%
cream (30)
£3.34
Mometasone
0.1%
cream (100)
£8.36
Mometasone
0.1%
ointment (100)
£8.21
Nebivolol
5mg
tablets (28)
£2.99
Pioglitazone
45mg
tablets (28)
£3.80
Topiramate
25mg
tablets (60)
£5.45
Topiramate
50mg
tablets (60)
£10.00

Do these prices reflect the ones you have paid in July so far?

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD005446

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel